Dr. Nadiya Ginzburg, MD

Dr. Ginzburg practices at Palomar Medical Center Escondido in Escondido, California.

Dr. Ginzburg's NPI, 1710419262, was assigned on April 3, 2017. Dr. Ginzburg holds California license A165689.

Dr. Ginzburg's primary practice is Palomar Medical Center Escondido, at 2185 Citracado Pkwy, Escondido, CA 92029 in San Diego County. The practice phone is (442) 281-5000.

Dr. Ginzburg's primary practice is Palomar Medical Center Escondido in Escondido, California. Dr. Ginzburg is also affiliated with Palomar Medical Center Downtown Escondido. The medical group on file is Emergency and Acute Care Medical Corporation. Dmand AI also links Dr. Ginzburg to 2 more hospitals, 4 medical groups and 1 hospice, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ginzburg practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Ginzburg's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Ginzburg is board certified in internal medicine by the American Board of Internal Medicine. Dr. Ginzburg is licensed in California.

Dmand AI lists acute diabetes, acute respiratory failure, acute stomach ulcer, atrial fibrillation and flutter, bile duct problems, cardiac arrhythmia, cellulitis and chronic anemia among the conditions Dr. Ginzburg treats.

CMS data shows 1,279 Medicare services from Dr. Ginzburg across 6 procedure codes in 2024, for 440 Medicare patients. Medicare paid $123,144 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 440 Medicare patients who saw Dr. Ginzburg in 2024. The largest group is 65 to 74, with 156 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 42% are also on Medicaid. Their average risk score is 2.73, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ginzburg's median patient age at 72, with 48% women.

In 2024, Dr. Ginzburg wrote 494 Medicare Part D claims for 212 patients. 90% of them were for generic drugs. CMS names the drug for 247 of them, across 13 drugs with 11 or more claims each, at $8,132 in total drug cost. In 2023, CMS named 146 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 98 out of 100 for Dr. Ginzburg for performance year 2024, reported as part of a group. Dr. Ginzburg accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 8 general payments to Dr. Ginzburg from 4 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 100% of the total. Innocoll Pharmaceuticals Limited paid the most, $131.

Dr. Ginzburg is in network with 4 carriers, including Aetna, Blue Cross Blue Shield of Massachusetts and HCSC. Medicare plans come from the most carriers, 4. Check the plan with the practice before a visit.